Valion Bio, Inc.
VBIO· Nasdaq
VBIOValion Bio, Inc.
Filed Mar 31, 2022 · 10-K · 90 days after period end · 0001104659-22-041068
derived · Computed from the longer spans the company filed.
no prior Q4 2020 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2021 · filed Mar 31, 2022 · 90 d after period end
Valion Bio, Inc. · CIK 1787740 · Engraved from SEC EDGAR
